Joint analysis of left ventricular expression and circulating plasma levels of Omentin after myocardial ischemia.
Louis A SaddicSarah M NicoloroOlga T GuptaMichael P CzechJoshua GorhamStanton K ShernanChristine E SeidmanJon G SeidmanSary F ArankiSimon C BodyTimothy P FitzgibbonsJochen Daniel MuehlschlegelPublished in: Cardiovascular diabetology (2017)
Myocardial injury leads to a decrease in ITLN1 expression in the heart and a corresponding increase in plasma levels. These changes may in part be due to an epithelial to mesenchymal transition of the cells that express ITLN1 following ischemia. Trial Registration Clinicaltrials.gov ID: NCT00985049.
Keyphrases
- left ventricular
- poor prognosis
- heart failure
- induced apoptosis
- binding protein
- clinical trial
- acute myocardial infarction
- study protocol
- hypertrophic cardiomyopathy
- atrial fibrillation
- randomized controlled trial
- mitral valve
- phase iii
- cardiac resynchronization therapy
- percutaneous coronary intervention
- placebo controlled